We have characterized the in cis interaction between p53 and estrogen receptors that can result in transcriptional modulation of the FLT1 promoter containing a p53 responsive SNP in a breast cancer cell model where estrogen responses might be expected to be more significant. Here, FLT1 is linked to breast carcinoma.